OPEN Foundation· Dilara Oexemann·AI score62
Analysis examines what a meta-analysis of psychedelics versus antidepressants shows
Psychedelics vs Antidepressants: What a New Meta-Analysis Really Shows
AI summary
An analysis by Dilara Oexemann for the OPEN Foundation examines a meta-analysismeta-analysisA statistical method that combines the results of several studies into one estimate.Open the glossary published in JAMA Psychiatry in March 2026 by Williams.
Key facts
- Kind of item
- Analysis and opinion
- Compound
- Psilocybin
- Condition
- Depression
- Regulator
- FDA (United States)
- Source
- OPEN Foundation (open-foundation.org)
- Published
- Original
- Read it at open-foundation.org
How this summary was made
The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: OPEN Foundation · open-foundation.org
Connected to
- Kind of item
- Analysis and opinion
- Compound
- Psilocybin
- Condition
- Depression
- Regulator
- FDA (United States)
- Theme
- Mechanisms